肺毛细血管炎是致命的扩散膜出血的原因
Christine Suess1, Melanie Schwartz2, Roland Hausmann2
1Institute of Legal Medicine, Cantonal Hospital St. Gallen, Rorschacherstrasse 95, CH-9007, St. Gallen, Switzerland. christineelisabeth.suess@kssg.ch.
International journal of legal medicine
|July 4, 2023
概括
妇女的突然,不明原因的死亡与急性扩散性肺出血有关. 尸检显示肺毛细血管的炎症,突出需要在法医病例进行彻底检查.
科学领域:
- 法医医学 法医医学
- 病理学 病理学 病理学
- 毒理学 毒理学 毒理学
背景情况:
- 致死性肺血栓溶解是法医学的重要发现,经常出现不特定的先前症状或缺少外部迹象.
- 急性气泡出血的差异诊断包括创伤性,物质相关,传染性和有机原因,可卡因使用和药物反应是突出的.
- 突然,意想不到的死亡需要全面的尸检调查,以确定潜在的原因,特别是当典型的指标缺席时.
研究的目的:
- 呈现两例女性突然,意外死亡的病例,临床和尸检结果相似.
- 调查急性扩散性肺出血,肺毛细血管急性炎症和最近疫苗接种史之间的潜在关联.
- 强调包括毒理学和组织学分析在内的完整尸检在确定罕见或未知的死亡原因方面的关键作用.
主要方法:
- 案例介绍两个已故的妇女突然,意想不到的死亡.
- 详细的尸检,包括尸检,组织学和毒理学分析.
- 对病史的审查,重点是最近的疫苗接种和潜在的暴露.
主要成果:
- 这两种病例都呈现出突然,意想不到的死亡,并具有相似的病史.
- 尸检显示,急性扩散性肺出血是由于肺毛细血管急性炎症引起的.
- 一名已故的个人在死亡前几个月接受了COVID-19疫苗接种.
结论:
- 由肺毛细血管急性炎症引起的急性扩散性肺出血可以导致突然,意想不到的死亡.
- 这些发现强调了全面尸检的必要性,包括毒理学和组织学,以诊断罕见的死亡原因.
- 记录和发布这些罕见病例对于医学研究至关重要,以探索潜在的未知关联,例如最近的疫苗接种.
相关概念视频
Pulmonary Embolism I: Introduction
9
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
9
Acute Respiratory Failure-II
278
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
278
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
Acute Respiratory Failure-III
228
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
228
Pneumonia II: Pathophysiology
359
The pathophysiology of pneumonia involves the following steps:
359
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
13
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
13


